News & Analysis on Clinical Trial Services & Contract Research And Development
Researchers believe that the discovery of enzymes that play a key role in building membranes of disease-causing bacteria has ended a 25-year mystery and paves the way for new drug development against certain types of bacteria.
The Pharsight Corporation has announced it has entered into the biggest single project workplan in the company's history utilising its drug-disease modelling, meta-data analysis and model visualisation services.
Drug giant Eli Lilly has joined forces with Suven Life Sciences in a deal that will focus on pre-clinical research of molecules in the therapeutic area of central nervous system (CNS) disorders.